ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer

Zhou, Cankun; Li, Chaomei; Zheng, Yuhua*; Huang, Xiaobin*南方医科大学
Frontiers in Oncology2022-10-27DOI: 10.3389/fonc.2022.934076
3被引6阅读
引用收藏
分享

摘要

BackgroundCuproptosis, a copper-dependent controlled cell death, is a novel form of cell death that differs from known cell death mechanisms; however, its overall regulation in cancer remains elusive. MethodsMultiple open-source bioinformatic platforms were used to comprehensively elucidate the expression levels, prognostic efficiency, potential biological functions, genomic and epigenetic characteristics, immune microenvironment, and drug sensitivity of cuproptosis regulators (ATP7A, ATP7B, DLAT, DLD, FDX1, GLS, LIAS, LIPT1, MTF1, NLRP3, PDHA1, PDHB, and SLC31A1) in pan-cancer. ResultsCuproptosis-related genes (CRGs) were upregulated in most cancers tested. In KIRC, KIRP, LGG, MESO, and PCPG, most highly expressed CRGs predicted a better prognosis but poorer prognosis in patients with ACC, LIHC, and UCEC. Pathway analysis confirmed that cuproptosis regulators were associated with the metabolism-related pathways. The expression of MTF1, NLRP3, and SLC31A1 was positively related with ImmuneScore, StromalScore, and ESTIMATEScore in almost all types of tumor, whereas ATP7B, DLAT, DLD, LIAS, PDHA1, and PDHB were significantly negatively correlated with the scores. In addition, CRGs were significantly correlated with RNA stemness score, DNA stemness score, microsatellite instability, and tumor mutational burden. The expression of ATP7A, ATP7B, LIAS, and DLAT was significantly positively correlated with the drug sensitivity of Docetaxel. ATP7A, LIAS, and FDX1 were significantly negatively correlated with the drug sensitivity of UNC0638, XMD13-2, YM201636, and KIN001-260. ConclusionsThe altered genomic and clinical characteristics of cuproptosis regulators were comprehensively elucidated, providing a preliminary basis for understanding the functions of cuproptosis in pan-cancer.

学科与关键词

关键词
cuproptosispan-cancergenomicstumor microenvironmentimmune
相关
加载中…
  • Comprehensive Analysis of Cuproptosis Genes and Identification of Cuproptosis Subtypes in Breast Cancer
    Li, Jialin; Li, Lei*; Dong, Yi; Zhong, Bin; Yin, WeiCOMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26(8): 1578-1593.
  • Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
    Xu, Jiahao; Hu, Zhengang; Cao, Hui; Zhang, Hao; Luo, Peng; Zhang, Jian; Wang, Xiaoyan; Cheng, Quan*; Li, Jingbo*Frontiers in Immunology, 2022, 13: 981764.被引 11
  • Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity
    Wang, Honglei; Li, Jinqiao; Zi, Xiaolin; Yuan, Xueli*Frontiers in Oncology, 2023, 13: 1116305.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-10-27
卷期
第 12 卷
页码
934076
DOI
10.3389/fonc.2022.934076
期刊等级
3区
成果收录
SCIE
资助标注
Foshan Transnatural Cavity Surgery Development and Innovation Engineering Technology Research Center [2020001003507]; 2020 Foshan City self-financing science and technology projects [2020001005656]

作者

  • Z

    Zhou, Cankun (第一作者)

    southern med univ

  • L

    Li, Chaomei

    southern med univ

查看全部 4 位作者收起作者
  • Z

    Zheng, Yuhua (通讯)

    southern med univ

  • H

    Huang, Xiaobin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417